Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus

NCT02388997 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: omalizumab
BIOLOGICAL: Rhinovirus (strain 16)

Sponsor

University of Virginia

Collaborators

[object Object]